Abstract: An image processing controller for a display device includes a fixed-point circuitry and a plurality of neural network blocks cascaded sequentially. The fixed-point circuitry is electrically connected to each neural network block, and configured to receive a feature signal corresponding to an output feature map about the display device from each neural network block, perform fixed-point processing on the feature signal to acquire fixed-point data within a design accuracy range, and input the fixed-point data as an input feature map to a next-level neural network block.

Abstract: The invention relates to a method of treatment comprising administering a long-acting mutant human fibroblast growth factor to a subject in need thereof. The said long-acting mutant human fibroblast growth factor is mPBG-CH2-N?H-mFGF21, wherein mFGF21 consists of SEQ ID NO:1, and the said new use consists of a method of treating non-alcoholic steatohepatitis.

Abstract: The present invention relates to a compound of formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and a use thereof in the preparation of a drug for treating diseases related to WEE1 activity.

Abstract: An electronic apparatus is provided. The electronic apparatus includes a touch control device configured to detect a touch; a processor configured to classify the touch into one of at least two modes; a haptic device configured to produce a haptic action accompanying an individual touch action; and a driving circuit configured to drive the haptic device. The processor is configured to, upon determination that the touch is of a first mode, transmit a first driving signal to the driving circuit. The driving circuit is configured to, upon receiving the first driving signal, drive the haptic device to produce a plurality of sub-actions cumulatively achieving at least a part of the haptic action accompanying the individual touch action. At least two sub-actions of the plurality of sub-actions are different from each other in at least one parameter.

Abstract: The invention relates to a method of treatment comprising administering a long-acting mutant human fibroblast growth factor to a subject in need thereof. The said long-acting mutant human fibroblast growth factor is mPEG-CH2—N?H-mFGF21, wherein mFGF21 consists of SEQ ID NO: 1, and the said new use consists of a method of treating non-alcoholic steatohepatitis.

Abstract: A cross-device allocation method for a service element includes obtaining a to-be-allocated service element from a source device; determining a preset matching relationship between each to-be-allocated service element and each target allocation device, where the preset matching relationship describes a probability value that each service element is allocated to each target allocation device; obtaining a distance relationship between each target allocation device and the source device; determining a correspondence between each service element and each target allocation device according to the preset matching relationship and the distance relationship; and allocating, according to the correspondence, each service element to the target allocation device corresponding to the service element.

Abstract: A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.

Abstract: An electronic apparatus is provided. The electronic apparatus includes a touch control device configured to detect a touch; a processor configured to classify the touch into one of at least two modes; a haptic device configured to produce a haptic action accompanying an individual touch action; and a driving circuit configured to drive the haptic device. The processor is configured to, upon determination that the touch is of a first mode, transmit a first driving signal to the driving circuit. The driving circuit is configured to, upon receiving the first driving signal, drive the haptic device to produce a plurality of sub-actions cumulatively achieving at least a part of the haptic action accompanying the individual touch action. At least two sub-actions of the plurality of sub-actions are different from each other in at least one parameter.

Abstract: The present application relates to an antidepressant and anxiolytic substituted cinnamamide compound, i.e., compound M2. The present application also provides a pharmaceutical composition containing compound M2 or a solvate thereof or a pharmaceutically acceptable salt thereof, and an antidepressant, anxiolytic, or antidepressant and anxiolytic application.

Abstract: Provided are a new class of compounds having a WEE1 inhibitory effect and as represented by formula I, and the use thereof in the preparation of a drug.

Abstract: The disclosure provides a video image transmission method, including: capturing and uploading video images to a cloud server in real time, by a video image capture terminal; acquiring first speed information of uploading the video images by the video image capture terminal and second speed information of receiving the video images by the cloud server; determining, according to first speed information, second speed information and a current ratio n of a first frame rate at which the video image capture terminal captures the video images and a second frame rate at which the video image capture terminal uploads the video images, a target ratio m of the first frame rate to the second frame rate, the target ratio m and the current ratio n being both positive integers; and adjusting, according to the target ratio m, a speed at which the video image capture terminal uploads the video images, to match an adjusted speed at which the video image capture terminal uploads the video images with a speed at which the cloud

Abstract: A three-dimensional scene constructing method, apparatus and system, and a storage medium. The three-dimensional scene constructing method includes: acquiring point cloud data of a key object and a background object in a target scene, wherein the point cloud data of the key object comprises three-dimensional information and corresponding feature information, and the point cloud data of the background object at least comprises three-dimensional information; establishing a feature database of the target scene, wherein the feature database at least comprises a key object feature library for recording three-dimensional information and feature information of the key object; performing registration and fusion on the point cloud data of the key object and the point cloud data of the background object, so as to obtain a three-dimensional model of the target scene; and when updating the three-dimensional model, reconstructing the three-dimensional model in a regional manner according to the feature database.

Abstract: The embodiment of the present disclosure provides a positioning method, a positioning device and system, an electronic equipment and a computer readable medium. The positioning method comprises: establishing connection with a target node in response to feedback information returned by the target node; acquiring initial position information; acquiring real-time position information for multiple times; and positioning the target node according to the acquired initial position information and the real-time position information acquired for multiple times. wherein the real-time position information comprises the direction and the distance of the movement of the source node relative to the last position of the source node, the direction and the distance of the movement of the target node returned by the target node relative to the last position of the target node, and the distance between the target node and the source node.

Abstract: The present invention provides a pharmaceutical composition for treating myocardial ischemia, comprising Salvia Miltiorrhiza medicinal material 250-700 parts by weight, Radix Notoginseng medicinal material 50-150 parts by weight, Borneolum Syntheticum 3-9 parts by weight, and ranolazine 25-100 parts by weight. According to a further aspect of the present invention, there is provided a use of a pharmaceutical composition for preparation of a medicine for prevention and/or treatment of myocardial ischemia.

Abstract: A data transmission method, includes: receiving N data packets sent by a communication opposite-end device, wherein each data packet includes a piece of target data, and N is a positive integer greater than 1; according to a receiving sequence of the N data packets from a first data packet to an Nth data packet, sequentially determining whether a transmission error occurs in each data packet; if it is determined that a data packet is transmitted incorrectly, storing, in a first queue, a piece of first indication information which indicates the data packet is transmitted incorrectly; and after it is determined that the reception of the N data packets ends, generating a first retransmission instruction, and sending the first retransmission instruction to the communication opposite-end device, wherein the first retransmission instruction includes information in the first queue.

Abstract: The present invention belongs to the technical field of biological pharmacy, and particularly relates to a long-acting HM-3 fusion protein molecule and an application thereof. In the present invention, on the basis of the sequence of HM-3 molecule, an active polypeptide HM-3 and derivatives thereof are linked to a human Fc (IgG) fragment or a fragment of an Fc (IgG) mutant directly or by a linker peptide (Linker), thus forming a novel molecular entity. The general formula of the molecular entity is (HM-3)n-Linker-Fc(IgG), Fc(IgG)-Linker-(HM-3)n, or (HM-3)n-Linker-Fc(IgG)-Linker-(HM-3)n. The fusion protein effectively prolongs the half-life of HM-3, is low in cost and overcomes the major problem of druggability of small peptides. Therefore, the fusion protein of the present invention may serve as a potential drug for the treatment of autoimmune diseases, neovascular diseases, osteoarthritis and the like.

Abstract: A cross-device allocation method for a service element includes obtaining a to-be-allocated service element from a source device; determining a preset matching relationship between each to-be-allocated service element and each target allocation device, where the preset matching relationship describes a probability value that each service element is allocated to each target allocation device; obtaining a distance relationship between each target allocation device and the source device; determining a correspondence between each service element and each target allocation device according to the preset matching relationship and the distance relationship; and allocating, according to the correspondence, each service element to the target allocation device corresponding to the service element.

Abstract: An interface layout method, apparatus, and system are described. A first terminal device receives a screen projection instruction that is used to instruct the first terminal device to perform screen projection to a second terminal device. The first terminal device generates, based on interface information of a first interface and second device information, a second interface to be displayed on the second terminal device, where the first interface is an interface displayed on the first terminal device. The second device information is used to indicate a screen size and a screen status of the second terminal device.

Abstract: A data transmission method, includes: receiving N data packets sent by a communication opposite-end device, wherein each data packet includes a piece of target data, and N is a positive integer greater than 1; according to a receiving sequence of the N data packets from a first data packet to an Nth data packet, sequentially determining whether a transmission error occurs in each data packet; if it is determined that a data packet is transmitted incorrectly, storing, in a first queue, a piece of first indication information which indicates the data packet is transmitted incorrectly; and after it is determined that the reception of the N data packets ends, generating a first retransmission instruction, and sending the first retransmission instruction to the communication opposite-end device, wherein the first retransmission instruction includes information in the first queue.